halofuginone has been researched along with Cirrhoses, Experimental Liver in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fevery, J; Nevens, F; Roskams, T; Van de Casteele, M; Van der Elst, I; van Pelt, JF | 1 |
Gildor, T; Mawasi, N; Ohayon, O; Paizi, M; Pevzner, A; Pines, M; Rojkind, M; Spira, G; Tryvitz, A | 1 |
Genina, O; Knopov, V; Lavelin, I; Nagler, A; Pines, M | 1 |
3 other study(ies) available for halofuginone and Cirrhoses, Experimental Liver
Article | Year |
---|---|
Halofuginone can worsen liver fibrosis in bile duct obstructed rats.
Topics: Aminopyrine; Animals; Bile Ducts; Breath Tests; Cholestasis, Extrahepatic; Collagen Type I; Collagen Type III; Disease Models, Animal; Ligation; Liver; Liver Cirrhosis, Biliary; Liver Cirrhosis, Experimental; Male; Piperidines; Portal Pressure; Quinazolines; Quinazolinones; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2004 |
Halofuginone upregulates the expression of heparanase in thioacetamide-induced liver fibrosis in rats.
Topics: Animals; Glucuronidase; Hydroxyproline; Liver Cirrhosis, Experimental; Liver Regeneration; Male; Piperidines; Protein Synthesis Inhibitors; Quinazolinones; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thioacetamide; Transfection; Up-Regulation; Vascular Endothelial Growth Factor A | 2008 |
Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis.
Topics: Alkaline Phosphatase; Animals; Collagen; Dimethylnitrosamine; Gene Expression; In Situ Hybridization; Injections, Intraperitoneal; Liver; Liver Cirrhosis, Experimental; Male; Piperidines; Protein Synthesis Inhibitors; Quinazolines; Quinazolinones; Rats; Rats, Sprague-Dawley | 1997 |